Immunotherapy demonstrates long-term success in treating lymphoma

(American Society of Hematology) Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT). This study was published online today in Blood, the official journal of the American Society of Hematology.

source : www.eurekalert.org

Related News:

• Treating Multiple Sclerosis With Antihypertensive Drug
• Treating Kidney Failure Using Genetically Modified Cell Procedure
• New use for old drugs in treating hepatitis C
• Treating Gum Disease May Lower Blood Glucose In Type 2 Diabetics
• Treating Alzheimer’s Could Save U.S. Trillions
• New Targeted Therapy Effective In Treating Advanced Prostate Cancer
• Accelerated Radiotherapy Regimen Shows Potential For Treating Head And Neck Cancer In Resource-Limited Countries
• It’s Not Just A Guy Thing: Treating Hair Loss In Women Is Focus Of Mayo Clinic Health Letter
• Potential new target for treating hepatitis C
• Treating Back Pain In Blood Marrow Cancer Patients

Details :
Submited at Friday, October 30th, 2009 at 6:00 pm on Cancer and Oncology by hilman
Comment RSS 2.0 - leave a comment - trackback